Literature DB >> 28603288

Osthole pretreatment alleviates TNBS-induced colitis in mice via both cAMP/PKA-dependent and independent pathways.

Wu Sun1, Yun Cai1, Xin-Xin Zhang1, Hao Chen1, Yan-Die Lin1, Hao Li1.   

Abstract

Osthole, a natural coumarin found in traditional Chinese medicinal plants, has shown multiple biological activities. In the present study, we investigated the preventive effects of osthole on inflammatory bowel disease (IBD). Colitis was induced in mice by infusing TNBS into the colonic lumen. Before TNBS treatment, the mice received osthole (100 mg·kg-1·d-1, ip) for 3 d. Pretreatment with osthole significantly ameliorated the clinical scores, colon length shortening, colonic histopathological changes and the expression of inflammatory mediators in TNBS-induced colitis. Pretreatment with osthole elevated serum cAMP levels; but treatment with the PKA inhibitor H89 (10 mg·kg-1·d-1, ip) did not abolish the beneficial effects of osthole on TNBS-induced colitis. In mouse peritoneal macrophages, pretreatment with osthole (50 μmol/L) significantly attenuated the LPS-induced elevation of cytokines at the mRNA level; inhibition of PKA completely reversed the inhibitory effects of osthole on IL-1β, IL-6, COX2, and MCP-1 but not on TNFα. In Raw264.7 cells, the p38 inhibitor SB203580 markedly suppressed LPS-induced upregulation of the cytokines, whereas the PKA inhibitors H89 or KT5720 did not abolish the inhibitory effects of SB203580. Moreover, in LPS-stimulated mouse peritoneal macrophages, SB203580 strongly inhibited the restored expression of IL-1β, IL-6, COX2, and MCP-1, which was achieved by abolishing the suppressive effects of osthole with the PKA inhibitors. Western blot analysis showed that osthole significantly suppressed the phosphorylation of p38, which was induced by TNBS in mice or by LPS in Raw264.7 cells. Inhibition of PKA partially reversed the suppressive effects of osthole on p38 phosphorylation in LPS-stimulated cells. Collectively, our results suggest that osthole is effective in the prevention of TNBS-induced colitis by reducing the expression of inflammatory mediators and attenuating p38 phosphorylation via both cAMP/PKA-dependent and independent pathways, among which the cAMP/PKA-independent pathway plays a major role.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28603288      PMCID: PMC5547558          DOI: 10.1038/aps.2017.71

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  32 in total

Review 1.  Glucocorticoid resistance in inflammatory bowel disease.

Authors:  R J Farrell; D Kelleher
Journal:  J Endocrinol       Date:  2003-09       Impact factor: 4.286

2.  Osthole Attenuates Inflammatory Responses and Regulates the Expression of Inflammatory Mediators in HepG2 Cells Grown in Differentiated Medium from 3T3-L1 Preadipocytes.

Authors:  Shu-Ju Wu
Journal:  J Med Food       Date:  2015-04-15       Impact factor: 2.786

3.  The acute toxic effect of the phosphodiesterase inhibitor rolipram on plasma osmolality.

Authors:  I Sturgess; G F Searle
Journal:  Br J Clin Pharmacol       Date:  1990-03       Impact factor: 4.335

Review 4.  Phosphodiesterase isozymes: molecular targets for novel antiasthma agents.

Authors:  T J Torphy
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

5.  The specific type-4 phosphodiesterase inhibitor mesopram alleviates experimental colitis in mice.

Authors:  Florian Loher; Kathrin Schmall; Philipp Freytag; Nikola Landauer; Roland Hallwachs; Christian Bauer; Britta Siegmund; Florian Rieder; Hans-Anton Lehr; Marc Dauer; Joachim Friedrich Kapp; Stefan Endres; Andreas Eigler
Journal:  J Pharmacol Exp Ther       Date:  2003-02-11       Impact factor: 4.030

6.  Mechanism of osthole inhibition of vascular Ca(v)1.2 current.

Authors:  Fabio Fusi; Giampietro Sgaragli; Le Minh Ha; Nguyen Manh Cuong; Simona Saponara
Journal:  Eur J Pharmacol       Date:  2012-02-04       Impact factor: 4.432

7.  Effect of the Chinese herb extract osthol on IL-4-induced eotaxin expression in BEAS-2B cells.

Authors:  Pu-Rong Chiu; Wei-Te Lee; Yu-Te Chu; Min-Sheng Lee; Yuh-Jyh Jong; Chih-Hsing Hung
Journal:  Pediatr Neonatol       Date:  2008-08       Impact factor: 2.083

8.  Anti-inflammatory effect and mechanism of osthole in rats.

Authors:  Jianxin Liu; Wenping Zhang; Li Zhou; Xiurong Wang; Qishen Lian
Journal:  Zhong Yao Cai       Date:  2005-11

Review 9.  Cyclic AMP: master regulator of innate immune cell function.

Authors:  Carlos H Serezani; Megan N Ballinger; David M Aronoff; Marc Peters-Golden
Journal:  Am J Respir Cell Mol Biol       Date:  2008-03-06       Impact factor: 6.914

10.  By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer.

Authors:  Yu-Ching Wen; Wei-Jiunn Lee; Peng Tan; Shun-Fa Yang; Michael Hsiao; Liang-Ming Lee; Ming-Hsien Chien
Journal:  Oncotarget       Date:  2015-08-28
View more
  5 in total

1.  Osthole prevents tamoxifen-induced liver injury in mice.

Authors:  Wen-Bo Zhou; Xin-Xin Zhang; Yun Cai; Wu Sun; Hao Li
Journal:  Acta Pharmacol Sin       Date:  2018-10-12       Impact factor: 6.150

2.  Osthole enhances the immunosuppressive effects of bone marrow-derived mesenchymal stem cells by promoting the Fas/FasL system.

Authors:  Yang Yu; Meng Chen; Shiyao Yang; Bingyi Shao; Liang Chen; Lei Dou; Jing Gao; Deqin Yang
Journal:  J Cell Mol Med       Date:  2021-03-21       Impact factor: 5.310

Review 3.  Coumarin Derivatives in Inflammatory Bowel Disease.

Authors:  Luiz C Di Stasi
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

4.  Osthole-Mediated Inhibition of Neurotoxicity Induced by Ropivacaine via Amplification of the Cyclic Adenosine Monophosphate Signaling Pathway.

Authors:  WeiBing Wang; Hui Zhou; LaiBao Sun; MeiNa Li; FengJiao Gao; AiJiao Sun; XueNong Zou
Journal:  Dose Response       Date:  2022-03-31       Impact factor: 2.658

5.  Effects of Osthol Isolated from Cnidium monnieri Fruit on Urate Transporter 1.

Authors:  Yuusuke Tashiro; Ryo Sakai; Tomoko Hirose-Sugiura; Yukio Kato; Hirotaka Matsuo; Tappei Takada; Hiroshi Suzuki; Toshiaki Makino
Journal:  Molecules       Date:  2018-11-01       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.